A relentless dryness that makes every bite of food a challenge and every conversation uncomfortable—this is the reality for millions living with salivary gland dysfunction. But regenerative medicine is pioneering solutions that could finally restore natural saliva production.
Patients with Sjögren's syndrome, cancer survivors, and others suffer from xerostomia
Adult stem cells offer potential for permanent restoration of salivary function
Advanced techniques like 3D bioprinting create new possibilities
For patients suffering from Sjögren's syndrome, head and neck cancer survivors who underwent radiation therapy, and many others, dry mouth (xerostomia) is a debilitating condition that severely impacts quality of life 7 . It turns simple pleasures like enjoying a meal into difficult tasks and increases the risk of oral infections, dental decay, and digestive issues.
While current treatments offer temporary relief, the revolutionary field of salivary gland regeneration aims to permanently restore function by repairing the damaged organs themselves. At the forefront of this research are adult stem cells and sophisticated tissue engineering strategies that could one day make dry mouth a problem of the past.
Nestled within our mouths are three pairs of major salivary glands—the parotid, submandibular, and sublingual glands—along with hundreds of minor glands 1 . Together, they produce one to two liters of saliva daily, a fluid essential for digestion, lubrication, swallowing, speaking, and protecting against harmful microbes 7 .
This complex system can be disrupted by autoimmune diseases like Sjögren's syndrome, where the body's own immune system attacks glandular tissue, or by radiation therapy for head and neck cancers, which inadvertently damages the delicate gland structures 7 . The result is often a profound and permanent reduction in saliva production.
Radiation therapy for head and neck cancers can permanently damage salivary gland tissue, leading to chronic dry mouth.
In Sjögren's syndrome, the immune system mistakenly attacks moisture-producing glands, including salivary glands.
The key to regeneration lies within the glands themselves: salivary gland stem/progenitor cells (SSPCs). These are rare, specialized adult stem cells that act as a built-in repair system, capable of generating new cells to maintain tissue homeostasis and heal injuries 1 .
In a healthy gland, these cells are mostly quiescent. However, following an injury like radiation damage, they become activated. Research using label-retaining cells (LRCs) has shown that these quiescent cells in the intercalated ducts and myoepithelium can differentiate into new, functional acinar cells—the cells responsible for saliva production—to repair the tissue 4 .
Harnessing the power of these cells for therapy has led to several innovative approaches in the lab.
The most straightforward strategy is isolating SSPCs from a healthy donor or the patient's own healthy tissue, expanding their numbers in the lab, and then transplanting them back into the damaged gland. Once transplanted, these cells can theoretically integrate into the tissue and differentiate into new, functional salivary cells 1 .
For extensively damaged glands, a more complex solution may be necessary: building a new gland from scratch. This involves using a combination of cells, supportive biomaterials (scaffolds), and biochemical cues to create a functional organ substitute 9 . Advanced techniques like 3D bioprinting are being explored to precisely arrange cells and materials into the intricate, branching structure of a natural salivary gland 9 .
SSPCs are isolated from healthy salivary gland tissue
Cells are expanded in culture using specialized media
Cells are guided to differentiate into functional salivary cells
Cells are transplanted into damaged glands to restore function
A significant hurdle in creating these therapies has been the inability to grow large numbers of human salivary gland cells in the lab. However, a 2025 study broke new ground by developing a chemical reprogramming culture (CRC) system for the long-term expansion of human salivary gland basal progenitor cells (SG-BPCs) 8 .
The experiment yielded several critical results confirming the method's success:
The expanded cells continued to express key progenitor cell markers like KRT5 and SOX9, proving they retained their progenitor identity even after massive expansion 8 .
When given the right signals, these expanded cells could differentiate into various salivary cell types, including acinar and myoepithelial cells 8 .
In the ultimate test, the researchers transplanted the lab-expanded human SG-BPCs into mice with radiation-induced salivary gland damage. The treatment successfully restored salivary gland function in the mice, demonstrating the therapeutic potential of these cells 8 .
The journey from a lab dish to a functional gland involves optimizing how cells interact. Another 2025 study investigated the optimal ratio of epithelial cells to supportive fibroblasts in 3D spheroid cultures, which better mimic the natural gland environment 5 .
| Ratio of Epithelial Cells to Fibroblasts | Spheroid Structural Integrity | Progenitor Marker (KRT5) Expression | Apoptosis and Senescence |
|---|---|---|---|
| 67% Epithelial / 33% Fibroblasts | High | Enhanced | Significantly Reduced |
| Other Tested Ratios | Lower | Lower | Higher |
Data adapted from Life 2025, 15(4), 607 5
To ensure future therapies can be widely studied and applied, researchers have established the first diverse salivary regenerative biobank at the Mayo Clinic. This repository collects and stores salivary gland tissues and organoids, providing an invaluable resource for the scientific community 6 .
| Characteristic | All Patients (N=208) | Male (N=113) | Female (N=95) |
|---|---|---|---|
| Race/Ethnicity | |||
| - White | 88.9% | 89.4% | 88.4% |
| - Other | 11.1% | 10.6% | 11.6% |
| Source | |||
| - Surgery | 53.4% | 56.6% | 49.5% |
| - Autopsy | 46.6% | 43.4% | 50.5% |
Data compiled from PMC12095476 6
Cutting-edge research in this field relies on a specific set of tools and reagents.
| Reagent / Tool | Category | Primary Function in Research |
|---|---|---|
| EpCAM Magnetic Beads | Cell Isolation | To separate epithelial cells from other cell types in gland tissue 5 |
| Y-27632 (ROCK inhibitor) | Small Molecule | Improves survival and proliferation of stem cells in culture 8 |
| A83-01 (TGF-β Inhibitor) | Small Molecule | Blocks differentiation signals, helping to maintain progenitor cells in a "stem-like" state 5 8 |
| Matrigel | Extracellular Matrix | A complex protein mixture used to support 3D cell growth and organoid formation, mimicking the natural cell environment 5 |
| FGF7/FGF10 | Growth Factor | Key signaling proteins that guide branching morphogenesis—the formation of the gland's tree-like structure 5 9 |
Scientists face several challenges in salivary gland regeneration research:
Recent breakthroughs have accelerated progress:
Despite exciting progress, challenges remain. Scientists are still working to ensure transplanted cells integrate permanently into the host tissue and form properly connected ductal systems. The issue of fibrosis (scarring) in damaged glands also creates a hostile environment that can block regeneration, requiring strategies to overcome it 7 9 .
Looking forward, the convergence of advanced bioprinting, microfluidic devices, and personalized stem cell therapies paints a hopeful picture. The ultimate goal is to create "living" salivary gland implants that can sense the oral environment and produce saliva on demand, fully integrating with the nervous system 9 .
Research into salivary gland regeneration is a powerful example of how stem cell biology and tissue engineering can come together to address a clear clinical need. For the millions waiting for a cure, the work happening in labs today promises a future where the simple, vital comfort of a moist mouth is restored.
Creating precise gland structures layer by layer
Using patient-specific cells for tailored treatments
Connecting regenerated glands to the nervous system